Carregant...

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer

Liang Huang,1,2,* Qi Liu,2,3,* Sheng Chen,1,2 Zhiming Shao1,2 1Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3Department of Radiation Oncology, Fudan Univ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Huang L, Liu Q, Chen S, Shao ZM
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017-12-01
Col·lecció:OncoTargets and Therapy
Matèries:
Accés en línia:https://www.dovepress.com/cisplatin-versus-carboplatin-in-combination-with-paclitaxel-as-neoadju-peer-reviewed-article-OTT
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!